Press Releases

MaaT Pharma, a clinical-stage biopharmaceutical company, received authorization from competent authorities to launch its phase…

The French Microbiome company completed its first clinical study proving that Autologous Fecal Microbiota Transfer…

Maat Pharma has reached the target number of patients to be treated in its first…

Quality, safety and reproducibility: more than a medical device, a technological breakthrough in the field…

MaaT Pharma’s disruptive business model: exponential growth.

Les Transferts de Microbiote Fécal (TMF) sont aujourd’hui utilisés afin de traiter certaines pathologies de…

Les Transferts de Microbiote Fécal (TMF) sont aujourd’hui utilisés afin de traiter certaines pathologies de…

MaaT Pharma and BIOASTER just entered into an agreement to investigate the potentiality to expand…

Louis Schweitzer a pu découvrir la première plateforme européenne répondant aux normes BPF de transfert…

Hervé Affagard a reçu le Trophée de l’Entrepreneur en Santé Homme